Single-use flexible ureteroscope market seen reaching $1.65B by 2030

The single-use flexible ureteroscope market is projected to grow from $0.98 billion in 2025 to $1.65 billion by 2030, driven by infection-control concerns, rising kidney disease, and wider use of minimally invasive urology. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Single-use flexible ureteroscopes lower cross-contamination risk by eliminating device sterilization between cases. - The market’s growth tracks rising demand for minimally invasive kidney stone and urinary tract procedures. - Chronic kidney disease is expanding the patient pool that needs advanced urological care.

What happened: - The Business Research Company projected the single-use flexible ureteroscope market will rise from $0.98 billion in 2025 to $1.08 billion in 2026. - The market is forecast to reach $1.65 billion by 2030. - The company said the market is growing at a 10.8% CAGR from 2025 to 2026 and an 11.0% CAGR through 2030. - The report was published July 22, 2026. - The source included a free sample request and the full market report.

The details: - A single-use flexible ureteroscope is a disposable instrument used for diagnostic or therapeutic procedures in the ureter and kidney. - The flexible design helps physicians navigate complex anatomy. - The disposable format removes the need for sterilization between uses. - The report linked growth to higher urolithiasis incidence, broader adoption of minimally invasive urology, stronger hospital endoscopy infrastructure, greater infection-control awareness, and wider clinical use of flexible ureteroscopy. - Forecast drivers include preference for single-use endoscopy devices, expansion of AI-guided urology interventions, growth in ambulatory surgical centers for kidney stone treatment, demand for sterile surgical environments, and advances in precision medicine. - The report highlighted disposables as a way to avoid cross-contamination and reduce sterilization and reprocessing costs. - In June 2023, Kidney Research UK said about 7.19 million people in the UK were living with chronic kidney disease, or more than 10% of the population. - Kidney Research UK projected that UK chronic kidney disease cases will rise to 7.61 million by 2033. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa.

Between the lines: - The market story is less about one device category and more about the shift toward single-use tools in infection-sensitive procedures. - Growth in outpatient kidney stone treatment suggests more procedures may move out of hospitals and into ambulatory centers. - The forecast implies device makers are betting on efficiency, safety, and reprocessing avoidance as the main buying triggers.

What's next: - The report expects continued adoption of disposable ureteroscopes as infection-control priorities stay elevated. - Expansion in Asia-Pacific could narrow the gap with North America as healthcare access and technology spending rise. - The Business Research Company said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, hotspot infographics, and future-trend analysis. - The company also pointed readers to its market intelligence platform, the Global Market Model, for updated forecasts.